Amputations: ‘A pandemic within the pandemic’
June 16, 2021
In our last article, we wrote about the impact of the COVID-19 pandemic on wound care and indicated how the use of DEBRICHEM® could provide
News & Updates
News & Updates Overview
In this section we give you an overview of the latest news and updates regarding the development of DEBx Medical and our product DEBRICHEM. Follow us on LinkedIn for more up-to-date content!
Archives
Ongoing impact of COVID-19
May 5, 2021
The impact of the ongoing pandemic on the overall healthcare systems is becoming more and more evident. COVID-19 is highly contagious, and its rapid spread
DEBx Medical virtually participating in the Innovation for Health 2021
April 15, 2021
This Thursday and Friday, DEBx Medical will be a virtual participant in the online edition of the Innovation for Health conference 2021. We will be
Microscopic video showing the disruption of bacteria upon administering a single drop of DEBRICHEM
April 6, 2021
DEBRICHEM is a disruptive new treatment option to address the infection in hard to heal wounds. The topical gel offers a very effective alternative to
DEBx Medical and DEBRICHEM featured on Bioworld MedTech
March 26, 2021
Last Friday, a new article about DEBx Medical and our product DEBRICHEM was published online on Bioworld Medtech. The article states, among other things, that
DEBx Medical receives Australian TGA approval for DEBRICHEM
March 19, 2021
Rotterdam, The Netherlands, March 19, 2021 – In early February, we finally obtained our ISO 13485:2016 certificate and our CE-certificate for DEBRICHEM. DEBRICHEM is a topical desiccantion gel for chemical
In Depth: Debridement
March 3, 2021
The presence of a biofilm in a wound is known to be detrimental to wound healing as is the case with the presence of necrosis
In Depth: Biofilms
March 3, 2021
Virtually all wounds contain bacteria but the type and number of bacteria, their phenotype, as well as the way they are organized determine to what
